Natural history and epidemiological study of multiple system atrophy in Hokkaido: HoRC-MSA 2014-2025
Objective: To investigate epidemiological information of multiple system atrophy (MSA) patients in Hokkaido, Japan by using the registry data from the Hokkaido Rare-disease Consortium for…Characterization of autonomic dysfunction in prodromal and early stages of Parkinson’s Disease
Objective: To evaluate cardiovascular autonomic dysfunction across prodromal stages of synucleinopathies (Pure Autonomic Failure-PAF); isolated REM Sleep Behavior Disorder-iRBD) and early stages of Parkinson’s disease…Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease
Objective: To evaluate transcranial magnetic stimulation (TMS) as a potential therapeutic tool for treatment of orthostatic hypotension (OH) in Parkinson’s disease (PD). Background: Autonomic dysfunction,…Prognostic role of postganglionic cardiovascular dysfunction in Multiple System Atrophy
Objective: To evaluate the role of reduced cardiac postganglionic sympathetic innervation as a prognostic factor in Multiple System Atrophy(MSA) Background: Cardiovascular autonomic dysfunction in MSA…Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.
Objective: To assess the relationships of long-term blood pressure (BP) measures and incident Parkinson’s disease (PD) in the Framingham Heart Study (FHS) cohort. Background: Long-term…Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD
Objective: To discover whether having probable rapid eye movement sleep behavior disorder (RBD) affects prevalence of particular autonomic symptoms, namely falls, constipation and urinary incontinence…Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?
Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites
Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Objective: To assess the long-term safety and tolerability of ampreloxetine in patients with synucleinopathies (MSA, PD, and PAF) and symptomatic neurogenic orthostatic hypotension (nOH) from…24-Hour Ambulatory Blood Pressure Monitoring and Dipping Patterns in Parkinson’s Disease and Multiple System Atrophy
Objective: To depict 24-hour blood pressure profile, especially dipping patterns, in individuals diagnosed with Parkinson’s Disease (PD) and Multiple System Atrophy (MSA). Background: Both PD…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 27
- Next Page »